Qiagen has won the US Food and Drug Administration (FDA) approval for its new molecular companion diagnostic product, therascreen KRAS RGQ PCR test kit, to provide guidance on the use of Erbitux for approximately 110,000 US patients with ...
Tags: Qiagen, FDA, molecular companion diagnostic product, test kit
Proacta, a San Diego based biotechnology company, has announced FDA approval of investigational new drug (IND) application for PR610, a hypoxia-activated irreversible multi-kinase inhibitor, for the treatment of cancer. With the IND ...
Tags: investigational new drug, IND
The UK Food Standards Agency (FSA) has issued a consumer warning, asking consumers – especially pregnant women, not to consume clay-based detox supplements and drinks as they may contain high levels of lead and arsenic. The agency ...
Tags: consumer warning, pregnant women, clay-based detox supplements
Japan's property/casualty insurer SBI Insurance has deployed Guidewire Software's InsuranceSuite service for underwriting, policy administration, billing and claims management. The new solution will be implemented by SBI Insurance for its ...
Tags: SBI Insurance, property insurer, casualty insurer, InsuranceSuite service
USA / UK - Everyone knows someone who's had cancer, and while no one can predict where or who it will strike, most people agree that encouraging healthy choices and receiving regular medical checkups are key to avoiding and treating the ...
Tags: cancer, annual checkups, simple screenings, Breast cancers
The Associated Press reported that construction workers assemble a gigantic steel arch to cover the remnants of the exploded reactor at the Chornobyl nuclear power plant in Ukraine. It will replace a sarcophagus built after the 1986 blast. ...
Tags: Chornobyl nuclear power plant, exploded reactor, steel arch
US insurance holding company Torchmark has purchased a privately owned supplemental health insurance provider Family Heritage Life Insurance Company of America, for nearly $232m. The transaction is expected to be immediately accretive to ...
Tokai Pharmaceuticals has gained FDA fast track designation for galeterone (TOK-001) for the potential treatment of metastatic castration-resistant prostate cancer (CRPC). Galeterone disrupts androgen receptor (AR) signaling, the key ...
Tags: galeterone, TOK-001, castration-resistant prostate cancer, CRPC
The European Commission has granted conditional marketing authorization for Pfizer’s Xalkori (crizotinib) to treat anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) in the European Union (EU). ...
Tags: Xalkori, crizotinib, anaplastic lymphoma kinase, ALK
The US Patent and Trademark Office (USPTO) has granted a patent for the use of Aeterna Zentaris' oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency (AGHD). AEZS-130, which has been granted ...
Tags: AEZS-130, growth hormone deficiency, AGHD
US Food and Drug Administration (FDA) has approved Pfizer's Bosulf (bosutinib) to treat adult patients with chronic, accelerated or blast phase Philadelphia chromosome-positive (Ph+) (CML) with resistance to prior therapy. Bosulif is a ...
Tags: bosulf, bosutinib, kinase inhibitor, Philadelphia chromosome-positive
Bayer HealthCare has filed a new drug application (NDA) with the FDA seeking approval for the oral multi-kinase inhibitor regorafenib to treat patients with metastatic colorectal cancer (mCRC). The company has even filed an application ...
Tags: oral multi-kinase inhibitor regorafenib, metastatic colorectal cancer
Critical Outcome Technologies has received a patent for its advanced oncology drug candidate, from the US Patent and Trademark Office. The patent covers the synergistic effects of combination therapies containing COTI-2 and members of ...
Tags: oncology drug, COTI-2, anti cancer agents
The European Commission (EC) has granted orphan drug designation to Sunesis Pharmaceuticals' Vosaroxin drug. Vosaroxin is a first-in-class anti-cancer quinolone derivative, (AQD), used for the treatment of acute myeloid leukemia (AML). ...
Tags: vosaroxin, AQD, AML, anti-cancer quinolone derivative
Coronado Biosciences has received notice of allowance for US patent application covering CNDO-109, from the US Patent and Trademark Office (USPTO). The patent is entitled, Method for activating natural killer cells by tumor cell ...
Tags: CNDO-109, cancer cells, AML